Lentiviral Gene Therapy Vectors Encoding VIP Suppressed Diabetes-Related Inflammation and Augmented Pancreatic Beta-Cell Proliferation

The authors suggest the observed therapeutic effect of lentiviral vector carrying VIP gene was due to the repression of diabetes-induced inflammation, its insulinotropic properties, and VIP-induced beta-cell proliferation.
[Gene Therapy]
Erendor, F., Sahin, E. O., Sanlioglu, A. D., Balci, M. K., Griffith, T. S., & Sanlioglu, S. (2020). Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation. Gene Therapy, 1–12. https://doi.org/10.1038/s41434-020-0183-3 Cite
Abstract

Continue reading “Lentiviral Gene Therapy Vectors Encoding VIP Suppressed Diabetes-Related Inflammation and Augmented Pancreatic Beta-Cell Proliferation”

Bookmark

No account yet? Register

0
Share

DGAT1 Inhibitors Protect Pancreatic β-Cells from Palmitic Acid-Induced Apoptosis

Researchers evaluated the potential beneficial effects of DGAT1 inhibitors on pancreatic β-cells, and further verified their antidiabetic effects in db/db mice.
[Acta Pharmacologica Sinica]
Huang, J., Guo, B., Wang, G., Zeng, L., Hu, Y., Wang, T., & Wang, H. (2020). DGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis. Acta Pharmacologica Sinica, 1–8. https://doi.org/10.1038/s41401-020-0482-7 Cite
Abstract

Continue reading “DGAT1 Inhibitors Protect Pancreatic β-Cells from Palmitic Acid-Induced Apoptosis”

Bookmark

No account yet? Register

0
Share

Targeting QKI-7 In Vivo Restores Endothelial Cell Function in Diabete

QKI-7 is highly expressed in human coronary arterial endothelial cells from diabetic donors, and on blood vessels from diabetic critical limb ischemia patients undergoing a lower-limb amputation.
[Nature Communications]
Yang, C., Eleftheriadou, M., Kelaini, S., Morrison, T., González, M. V., Caines, R., Edwards, N., Yacoub, A., Edgar, K., Moez, A., Ivetic, A., Zampetaki, A., Zeng, L., Wilkinson, F. L., Lois, N., Stitt, A. W., Grieve, D. J., & Margariti, A. (2020). Targeting QKI-7 in vivo restores endothelial cell function in diabetes. Nature Communications, 11(1), 3812. https://doi.org/10.1038/s41467-020-17468-y Cite
Full Article

Continue reading “Targeting QKI-7 In Vivo Restores Endothelial Cell Function in Diabete”

Bookmark

No account yet? Register

0
Share

Emerging Role of FBXO22 in Carcinogenesis

Scientists summarize the regulatory factors and downstream targets of F-box protein 22 (FBXO22) in cancers, discuss its functions in tumorigenesis, and further highlight the alteration of FBXO22 expression in a variety of human malignancies.
[Cell Death Discovery]
Cheng, J., Lin, M., Chu, M., Gong, L., Bi, Y., & Zhao, Y. (2020). Emerging role of FBXO22 in carcinogenesis. Cell Death Discovery, 6(1), 1–7. https://doi.org/10.1038/s41420-020-00303-0 Cite
Full Article

Continue reading “Emerging Role of FBXO22 in Carcinogenesis”

Bookmark

No account yet? Register

0
Share

High-Dimensional Single-Cell Analysis Delineates Radiofrequency Ablation Induced Immune Microenvironmental Remodeling in Pancreatic Cancer

Investigators indicated that radiofrequency ablation (RFA) treatment induced remodeling of tumor immune microenvironment in distant non-RFA tumors in pancreatic cancer mouse model.
[Cell Death & Disease]
Fei, Q., Pan, Y., Lin, W., Zhou, Y., Yu, X., Hou, Z., Yu, X., Lin, X., Lin, R., Lu, F., Guan, H., & Huang, H. (2020). High-dimensional single-cell analysis delineates radiofrequency ablation induced immune microenvironmental remodeling in pancreatic cancer. Cell Death & Disease, 11(7), 1–13. https://doi.org/10.1038/s41419-020-02787-1 Cite
Full Article

Continue reading “High-Dimensional Single-Cell Analysis Delineates Radiofrequency Ablation Induced Immune Microenvironmental Remodeling in Pancreatic Cancer”

Bookmark

No account yet? Register

0
Share

Genome-Scale In Vivo CRISPR Screen Identifies RNLS as a Target for Beta Cell Protection in Type 1 Diabetes

Using a genome-scale CRISPR screen in a mouse model for type 1 diabetes (T1D), researchers showed that deleting RNLS, a genome-wide association study candidate gene for T1D, made beta cells resistant to autoimmune killing.
[Nature Metabolism]
Cai, E. P., Ishikawa, Y., Zhang, W., Leite, N. C., Li, J., Hou, S., Kiaf, B., Hollister-Lock, J., Yilmaz, N. K., Schiffer, C. A., Melton, D. A., Kissler, S., & Yi, P. (2020). Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes. Nature Metabolism, 1–12. https://doi.org/10.1038/s42255-020-0254-1 Cite
Abstract

Continue reading “Genome-Scale In Vivo CRISPR Screen Identifies RNLS as a Target for Beta Cell Protection in Type 1 Diabetes”

Bookmark

No account yet? Register

0
Share

Identification of an Anti-Diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action

In rat cells and in mouse and human islets, SRI-37330 inhibited expression and signaling of thioredoxin-interacting protein, previously found to be elevated in diabetes and to have detrimental effects on islet function.
[Cell Metabolism]
Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action: Cell Metabolism. (n.d.). Retrieved July 28, 2020, from https://www.cell.com/cell-metabolism/fulltext/S1550-4131(20)30360-0 Cite
AbstractGraphical Abstract

Continue reading “Identification of an Anti-Diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action”

Bookmark

No account yet? Register

0
Share

Insulin2Q104del (Kuma) Mutant Mice Develop Diabetes with Dominant Inheritance

Scientists generated a novel Kuma mutant mice with p.Q104del in the Insulin2 gene in a BRJ background that exhibited a severe immune deficiency.
[Scientific Reports]
Sakano, D., Inoue, A., Enomoto, T., Imasaka, M., Okada, S., Yokota, M., Koike, M., Araki, K., & Kume, S. (2020). Insulin2 Q104del (Kuma) mutant mice develop diabetes with dominant inheritance. Scientific Reports, 10(1), 12187. https://doi.org/10.1038/s41598-020-68987-z Cite
Full Article

Continue readingInsulin2Q104del (Kuma) Mutant Mice Develop Diabetes with Dominant Inheritance”

Bookmark

No account yet? Register

0
Share

Invasion Inhibition in Pancreatic Cancer using the Oral Iron Chelating Agent Deferasirox

Researchers used pancreatic cancer cell lines (BxPC-3, Panc-1, and HPAF II) to examine the efficacy of iron chelator deferasirox in preventing invasion in vitro, evaluated using scratch assays and Boyden chamber assays.
[BMC Cancer]
Amano, S., Kaino, S., Shinoda, S., Harima, H., Matsumoto, T., Fujisawa, K., Takami, T., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2020). Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer, 20(1), 681. https://doi.org/10.1186/s12885-020-07167-8 Cite
Full Article

Continue reading “Invasion Inhibition in Pancreatic Cancer using the Oral Iron Chelating Agent Deferasirox”

Bookmark

No account yet? Register

0
Share

CircRHOT1 Mediated Cell Proliferation, Apoptosis and Invasion of Pancreatic Cancer Cells by Sponging miR-125a-3p

Investigators demonstrated that circRHOT1 was overexpressed in pancreatic cancer tissues and cell lines, and it was found to directly bind to miR‐125a‐3p, acting as an endogenous sponge to inhibit its activity.
[Journal of Cellular and Molecular Medicine]
Ling, S., He, Y., Li, X., Hu, M., Ma, Y., Li, Y., Lu, Z., Shen, S., Kong, B., Zou, X., Jiang, K., & Huang, P. (n.d.). CircRHOT1 mediated cell proliferation, apoptosis and invasion of pancreatic cancer cells by sponging miR-125a-3p. Journal of Cellular and Molecular Medicine, n/a(n/a). https://doi.org/10.1111/jcmm.15572 Cite
Full Article

Continue reading “CircRHOT1 Mediated Cell Proliferation, Apoptosis and Invasion of Pancreatic Cancer Cells by Sponging miR-125a-3p”

Bookmark

No account yet? Register

0
Share

Merus Announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer

Merus N.V. has announced that the US FDA has granted Orphan Drug Designation to Zenocutuzumab for the treatment of patients with pancreatic cancer.
[Merus N.V.]
Mae, S.-I., Ryosaka, M., Sakamoto, S., Matsuse, K., Nozaki, A., Igami, M., Kabai, R., Watanabe, A., & Osafune, K. (2020). Expansion of Human iPSC-Derived Ureteric Bud Organoids with Repeated Branching Potential. Cell Reports, 32(4). https://doi.org/10.1016/j.celrep.2020.107963 Cite
Press Release

Continue reading “Merus Announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer”

Bookmark

No account yet? Register

0
Share

French Science Bill Promises Boost to Public R&D

The French government this week unveiled a draft science bill that promises to increase public research spending with an extra €25 billion over the next ten years.
[ScienceInsider]
Press Release

Continue reading “French Science Bill Promises Boost to Public R&D”

Bookmark

No account yet? Register

0
Share
Share